Usefulness of intra-procedural cone-beam computed tomography in modified balloon-occluded retrograde transvenous obliteration of gastric varices

Table 1 Patient demographics

Patient demographics
Male:female	7:8
Age (yr)	59 (46-86)
Underlying liver disease n (%)
Hepatitis C cirrhosis	5 (33.3)
Alcoholic cirrhosis	3 (20.0)
Non-alcoholic steatohepatitis	3 (20.0)
Primary biliary cirrhosis	2 (13.3)
Hepatitis B cirrhosis	1 (6.7)
Cryotogenic cirrhosis	1 (6.7)
Concomitant malignancy n (%)
Hepatocellular carcinoma	1 (6.7)
Metastatic neuroendocrine tumor	1 (6.7)

Table 2 A technical and clinical summary of modified balloon-occluded retrograde transvenous obliteration

Technical summary of mBRTO
Technical Success rate	100% (15/15)
Clinical success rate	100% (15/15)
Follow-up period	684 ± 279 d
Major complication rate	0% (0/15)
CARTO
Number of coils used	10.7 ± 3.8
Diameters of coils used	5-15 mm
Number of gelfoam Pack used	5.6 ± 3.0
PARTO
Size of plugs used	18 mm (3/3)
Number of gelfoam pack used	9.0 ± 4.5

mBRTO: Modified balloon-occluded retrograde transvenous obliteration; CARTO: Coil-assisted retrograde transvenous obliteration; PARTO: Plug-assisted retrograde transvenous oblitearation.